A Marc Lichtenfeld Exclusive Event on Thursday, June 27 at 2 P.M. ET...
Why Nvidia Is Going All-In On This $10 TechBio Stock
And why you should get in before July 1 ahead of the next cash wave
Don't Miss Your Chance to Get In Early
on the AI Biotech Revolution!
Don't Miss Your Chance to Get In Early
on the AI Biotech Revolution!
Right under investors’ noses, the greatest AI stock story EVER is unfolding.
Nvidia, the $2.5 trillion artificial intelligence powerhouse, has just bet BIG on one under–the–radar biotech trading for just $10.
Why is the world’s #1 AI company investing in biotech?
Consider this...
Nvidia's investment portfolio consists of only 5 stocks total. And a shocking 97% of it is concentrated in just two holdings – with this $10 biotech being one of them.
THAT is how convinced the AI leader is that this tiny biotech will usher in the next great tech revolution.
Jensen Huang, the CEO of Nvidia agrees, saying this will be “...the next amazing revolution... It will be one of the biggest ever.”
And Nvidia has set themselves up for a massive windfall... investing just ahead of a bombshell announcement that could send shockwaves through the market.
You'll find out all of the details during this exclusive FREE webinar hosted by Marc Lichtenfeld, America's #1 stock catalyst expert.
The AI Biotech Revolution Is Coming –
Get in Before It's Too Late
During this must–attend LIVE event, Marc will pull back the curtain on this small company’s AI technology... How it could transform the $11 trillion healthcare, life sciences and pharma industries as we know it...
And create a potential life–changing windfall for early investors.
You'll see why Kimberly Powell, Nvidia's VP of Healthcare, believes "computer–aided drug discovery" could create "the next trillion–dollar drug company."
And most importantly, Marc will reveal the major announcement – coming within days –– that he says could light a raging fire under this $10 stock... and thrust the entire AI biotech revolution into hyperdrive.
This is the kind of catalyst that ignited his top trade recommendations like:
297%
Idexx Laboratories
in 5 months
286%
Auxilim Pharmaceuticals
in 4 months
907%
AbbVie
in under a year
Yet none was nearly as impactful as the coming catalyst for Nvidia’s favorite biotech.
But the clock is ticking. This bombshell announcement could come as soon as July 1. Which is why Marc has scheduled this exclusive event just ahead of it.
He’ll be making his biggest and boldest prediction yet. And you can get all the details.
Nvidia is perfectly positioned to grab a massive win. This is your opportunity to get in place next to them.
So if you want to get in on the ground floor of what could be an absolute game–changer for the future of AI, biotech and human health, you need to attend this FREE exclusive webinar on Thursday, June 27 at 2 P.M. ET.
During this special event, you’ll discover...
- The shocking details of how this firm that’s less than 1/10th the size of Nvidia was the one out of 6,600 biotechs that caught the eye of the AI giant. And how it led to a surprising partnership that could spark the next trillion–dollar company.
- Why an imminent announcement from this under–the–radar company could trigger a frenzy of buying and potential explosive gains – even greater than FDA approval.
- Three simple reasons this company’s small market cap could “automatically” triple.
- The unique way to play this developing situation that Marc Lichtenfeld believes could lead to "the greatest stock success story of our lifetime." It will position you for the biggest possible short–term gains and let you ride this company’s success all the way to the top.
- The lucrative catalyst events Marc has capitalized on before... Like the 907% gain in under a year that made one follower a rare $1.3 million. And you’ll hear details on how he spots these powerful catalysts.
SO DO NOT MISS THIS.
Make sure you grab your FREE ticket right here.
Featured Expert Marc Lichtenfeld
_UberShoot_2018-circle.png)
Marc Lichtenfeld
Chief Income Strategist
and Stock Catalyst Expert,
The Oxford Club
Best–selling financial author, Marc Lichtenfeld, is America’s #1 stock catalyst expert.
He’s spent decades studying and trading the biotech sector, having met privately with the doctor known as “the father of stem cell research”… a medical CEO ranked among Fortune Small Business 100’s richest executives… world famous scientists… managers of multi–million dollar biotech hedge funds... and more.
Marc has been a regular attendee at the invitation–only JP Morgan Healthcare Conference.
And since 2007, he’s helped countless Oxford Club members take their wealth to the next level through various research publications...
“You did a crazy–awesome job. Marc, you are THE MAN! But your math is lame (kidding!). You said a possible 173% gain? But I’m calculating a 493% gain in 3 months, right? I’m not sure. I’ve never had to calculate such crazy gains... Holy cow!”
Allen Kepler, Arizona
“Great win! I made 113% overnight!”
Shawn Foley, Texas
“I put $10,800 into the trade in August and made a profit of $24,000 by March. I’m taking that money and going to Hawaii in the winter!”
Terrence Beatty, Delaware
“I got crucified in 2009, losing 85% of my portfolio. Then, years later, I started building up a small base following your recommendations. I’m happy to report that my portfolio – though small – has increased 300% in the last 12 months. I’m excited every morning to look at my positions and wait for your next recommendation.”
Bart Bourke, Australia
“I'm a paralyzed veteran, 53 years old. I'm not able to work in a traditional job anymore. My wife and I have 6 kids and 6 grandkids, and we're able to spend more time with them now because we are financially independent.”
Bill Stanton, Montana